News
February 28, 2020

Regenstrief researcher leads Scottsdale webinar on hypoglycemia findings

Regenstrief Institute research scientist Michael Weiner, M.D., MPH, led a Scottsdale Institute webinar and presented his recent research findings related to hypoglycemia.

Dr. Weiner explained the statistical modeling that identified the magnitude of risk factors for hypoglycemia. He also discussed a pilot study using continuous glucometers and other wearable devices designed to make better predictions of glucose levels in older adults with diabetes who live in urban areas.

Dr. Weiner’s overall research focuses on measuring and improving the quality, coordination and delivery of health services for older adults. His research has included projects addressing hypoglycemia, a condition characterized by a low level of blood sugar and often related to the treatment of diabetes, along with personal habits. It can cause symptoms that include cognitive impairment and is also a risk factor for dementia.

The Scottsdale Institute is a not-for-profit membership organization of prominent healthcare systems. The institute’s goal is to support its members as they work to achieve clinical integration and transformation through information technology. The Scottsdale Institute provides forums, such as teleconferences, to promote collaboration, education and networking.

In addition to his role as a research scientist at Regenstrief, Dr. Weiner is an associate director of the William M. Tierney Center for Health Services Research at Regenstrief, director of the Veterans Affairs Health Services Research and Development Center for Health Information and Communication, and a professor of medicine at Indiana University School of Medicine.

More information on Dr. Weiner’s research.

  • Dr. Michael Weiner

Related News

LOINC version 2.81 release

Arabic and Czech translations, more than 4,000 new concepts boost global interoperability in latest LOINC® release

Regenstrief Institute’s latest LOINC® content update on August 12, introduces two new linguistic variants: Arabic, for users in Jordan,

Regenstrief President and CEO Rachel Patzer, PhD, MPH.

Regenstrief CEO among national honorees for ground-breaking achievements in transplantation

SAN FRANCISCO – Regenstrief Institute President and Chief Executive Officer Rachel Patzer, PhD, MPH, is among a select group

LOINC 2025 Conference - Montreal, Canada

Regenstrief to host 2025 LOINC® conference in Montréal, Canada, Oct. 7-10

First LOINC conference in Canada — home to one of LOINC’s largest user bases  Regenstrief Institute Health Data Standards

Katie Ross-Driscoll, PhD

Regenstrief researcher receives Showalter award to improve access to organ transplants using learning health systems approach

Regenstrief Institute Research Scientist Katie Ross-Driscoll, PhD, MPH, has been awarded a 2025 Ralph W. and Grace M. Showalter